StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Ajanta Pharma Limited
NSE:AJANTPHARM.NS
Sector
Location
Market Cap
USD 3.86 B
Share Price
USD 30.56
Avg Daily Volume
115,497
Change (1 day)
1.15%
Change (1 year)
15.40%
Change (YTD)
-10.77%
Ajanta Pharma Limited EBITDA Margin for the year ending March 31, 2025: 27.29%
Ajanta Pharma Limited EBITDA Margin is 27.29% for the year ending March 31, 2025, a -8.60% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
Ajanta Pharma Limited EBITDA Margin for the year ending March 31, 2024 was 29.86%, a 26.77% change year over year.
-
Ajanta Pharma Limited EBITDA Margin for the year ending March 31, 2023 was 23.55%, a -25.95% change year over year.
-
Ajanta Pharma Limited EBITDA Margin for the year ending March 31, 2022 was 31.80%, a -11.58% change year over year.
-
Ajanta Pharma Limited EBITDA Margin for the year ending March 31, 2021 was 35.97%, a 19.50% change year over year.
Competitors
Johnson & Johnson
USD 156.90
JNJ
-0.79
-0.50%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Haleon plc
USD 4.95
HLN.L
-0.10
-1.95%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.61
600436.SS
+0.02
0.08%
Yunnan Baiyao Group Co.,Ltd
USD 7.82
000538.SZ
+0.02
0.20%
Nahdi Medical Company
USD 34.29
4164.SR
-0.21
-0.61%
Rohto Pharmaceutical Co.,Ltd.
USD 13.97
4527.T
+0.05
0.35%
Jamjoom Pharmaceuticals Factory Company
USD 44.89
4015.SR
-0.05
-0.11%
Gerresheimer AG
USD 57.29
GXI.DE
-1.79
-3.03%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.63
600572.SS
+0.00
0.52%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
Johnson & Johnson
USD 156.90
JNJ
-0.79
-0.50%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Haleon plc
USD 4.95
HLN.L
-0.10
-1.95%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.61
600436.SS
+0.02
0.08%
Yunnan Baiyao Group Co.,Ltd
USD 7.82
000538.SZ
+0.02
0.20%
Nahdi Medical Company
USD 34.29
4164.SR
-0.21
-0.61%
Rohto Pharmaceutical Co.,Ltd.
USD 13.97
4527.T
+0.05
0.35%
Jamjoom Pharmaceuticals Factory Company
USD 44.89
4015.SR
-0.05
-0.11%
Gerresheimer AG
USD 57.29
GXI.DE
-1.79
-3.03%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.63
600572.SS
+0.00
0.52%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%